UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
October 8, 2003
Date of report (date of earliest event reported)
QUADRAMED CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 0-21031 52-1992861
(State or Other Jurisdiction of (Commission File (IRS Employer
Incorporation) Number) Identification No.)
12110 Sunset Hills Road, Suite 600, Reston, VA 20190
(Address of Principal Executive Offices)
(703) 709-2300
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former address, if Changed Since Last Report)
TABLE OF CONTENTS
-----------------
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1
--------------------------------------------------------------------------------
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
99.1 Transcript of QuadraMed Corporation's October 8, 2003 Investor
Conference Call
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On October 8, 2003, QuadraMed Corporation held an investor conference call.
During this conference call, information regarding the results of operations and
financial condition for past periods, including the completed quarterly period
ended September 30, 2003, was discussed. A copy of the transcript of this
conference is attached as Exhibit 99.1. To hear a replay of the call, visit
http://www.quadramed.com/Investors/Conference_Calls_and_Presentations.jsp
The information in this Current Report on Form 8-K is being furnished and
shall not be deemed "filed" for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section. The information in this Current Report shall not be incorporated
by reference into any registration statement or other document pursuant to the
Securities Act of 1933, as amended, except as shall be expressly set forth by
specific reference in such a filing.
--------------------------------------------------------------------------------
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: October 14, 2003
QuadraMed Corporation
/s/
------------------------
John C. Wright, Executive Vice President
and Corporate Secretary
----------------------------------------
--------------------------------------------------------------------------------
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Transcript of QuadraMed Corporation's October 8, 2003 Investor
Conference Call